Tips to help you start your patient advocacy journey Tips to help you start your patient advocacy journey Advocating for yourself as a patient can be daunting. Jeff Dunn, President of Union for International Cancer Control (UICC), shares some tips
EMPRISE EMPRISE Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care
cat feline diabetes medication treatment fda approval cat feline diabetes medication treatment fda approval Boehringer Ingelheim receives FDA approval for SENVELGO®
collaboration-proxygen-molecular-glue-degraders collaboration-proxygen-molecular-glue-degraders Boehringer Ingelheim collaborates with Proxygen to explore molecular glue degraders – a novel approach to fight cancer.
Phase II results cognitive impairment schizophrenia Phase II results cognitive impairment schizophrenia Presented at ECNP Congress, Phase II trial results demonstrated improvement in cognition with BI 425809 in schizophrenia patients
Fight against COVID-19 pandemic Fight against COVID-19 pandemic Press release on Boehringer Ingelheim's half-year figures 2020. Business development from January to June 2020.
Aservo EquiHaler wins Pharmapack Award 2021 Aservo EquiHaler wins Pharmapack Award 2021 Boehringer Ingelheim’s Aservo® EquiHaler® is recognized in the 2021 Pharmapack Awards
Research ruminant animal health well-being Research ruminant animal health well-being Boehringer Ingelheim supports young scientists and veterinarians dedicated to ruminant health research
Mastitis dairy cows prevent antibiotic resistance Mastitis dairy cows prevent antibiotic resistance The Clinical and Laboratory Standards Institute (CLSI) approved revised interpretive criteria for the susceptibility testing of a mastitis product.
A beginner’s guide to fighting off cat parasites A beginner’s guide to fighting off cat parasites Prof. Donato Traversa explains the risk of multiparasitic infections and/or infestations in cats
Boehringer Ingelheim partners with PetMedix Boehringer Ingelheim partners with PetMedix Partnering with PetMedix on Ky9™ platform cutting edge technology as a means to bring innovative new therapies to improve health of animals
Winners of the 2019 European PRRS Research Award Winners of the 2019 European PRRS Research Award Winners of the 2019 European PRRS Research Award announced.
Why we may be more like our pets than we think Why we may be more like our pets than we think The bond between owners and their pets goes beyond physical resemblance as we are increasingly facing similar health problems.
collaboration-Yale collaboration-Yale Yale-Boehringer Ingelheim Biomedical Data Science Fellowship Program Seeks to Attract Top Researchers from Around the World
Health Equity: No distance is too far Health Equity: No distance is too far India is hosting the G20 summit. The leading theme of the G20 summit emphasizes health equity and sustainability as part of the agenda. How we provide access to healthcare for rural areas in India.
New partnership to develop schizophrenia treatments New partnership to develop schizophrenia treatments Boehringer Ingelheim partners with Sosei Heptares to develop next generation schizophrenia treatments
antibiotic resistance one health veterinary medicine antibiotic resistance one health veterinary medicine Antimicrobial resistance is a major global threat to the health of humans and animals alike. Learn about challenges and solutions here.
Health equity for underserved communities Health equity for underserved communities Introducing initiatives that improve access to healthcare for underserved communities
On two wheels for more animal health On two wheels for more animal health Cowtribe’s social entrepreneurs win Boehringer Ingelheim's Accelerator Program.
FDA Grants Breakthrough Status to Schizophrenia Treatment FDA Grants Breakthrough Status to Schizophrenia Treatment Boehringer Ingelheim and Click Therapeutics receive FDA Breakthrough Device Designation for schizophrenia prescription digital therapeutic
Supporting Rabies Free Pakistan Indus Hospital Supporting Rabies Free Pakistan Indus Hospital Rabies endangers thousands of human lives in Pakistan every year. We provide green collars and vaccines to improve situation.
Henke-Sass Wolf develop needle free device Henke-Sass Wolf develop needle free device Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs
Survey with Ipsos to gain insights human-animal bond Survey with Ipsos to gain insights human-animal bond Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.
Approval for Aservo EquiHaler equine asthma therapy Approval for Aservo EquiHaler equine asthma therapy Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy
The power of patient advocacy in cancer care The power of patient advocacy in cancer care Larry, a retired US Navy veteran, and Jeff, UICC President, have more in common than a cancer diagnosis: they share a passion for patient empowerment.